Literature DB >> 21686582

Drug extravasation: a dreaded complication.

Esther Uña1, Fernando Cuadrillero, Francisco López-Lara.   

Abstract

A 62-year-old man diagnosed with a stage I lung adenocarcinoma was treated by an upper right lobectomy. Eighteen months later an elevation of carcinoembryoinc antigen (CEA) was detected, and CT tomography revealed a stage IV disease. Chemotherapy including cisplatin (Platinol) and docetaxel (Taxotere) was administered. He presented 12 days after receiving an intravenous infusion because he noticed a burning sensation, erythema and blisters at the site of the last infusion and proximal to that area. On physical examination he had a 9×4.5 cm swollen area of erythema and multiple blisters. The diagnosis of delayed and distant docetaxel extravasation was made. The treatment consisted of normal saline washes, topical hydrocortisone and antibiotic-based ointment which produced relief of the symptoms. This reaction resolved over the next 6 weeks, leaving two areas of brownish pigmentation of the skin as the only sequelae.

Entities:  

Year:  2009        PMID: 21686582      PMCID: PMC3028026          DOI: 10.1136/bcr.09.2008.0887

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Extravasation: a dreaded complication of chemotherapy.

Authors:  D L Schrijvers
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

Review 2.  Extravasation of systemic hemato-oncological therapies.

Authors:  R A Ener; S B Meglathery; M Styler
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

3.  Necrosis caused by extravasation of arginine hydrochloride.

Authors:  H A Bowlby; S I Elanjian
Journal:  Ann Pharmacother       Date:  1992-02       Impact factor: 3.154

Review 4.  Dermatologic toxicity of chemotherapeutic agents.

Authors:  Aimee S Payne; William D James; Raymond B Weiss
Journal:  Semin Oncol       Date:  2006-02       Impact factor: 4.929

5.  Cutaneous necrosis induced by extravasation of arginine monohydrochloride.

Authors:  Hiroo Amano; Yayoi Nagai; Takanori Kowase; Osamu Ishikawa
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

6.  Distant and delayed mitomycin C extravasation.

Authors:  J S Patel; M Krusa
Journal:  Pharmacotherapy       Date:  1999-08       Impact factor: 4.705

7.  Docetaxel extravasation.

Authors:  P Berghammer; R Pöhnl; M Baur; C Dittrich
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

8.  Docetaxel extravasation causing significant delayed tissue injury.

Authors:  J Raley; J P Geisler; T E Buekers; J I Sorosky
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

9.  Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations.

Authors:  J A Ascherman; S L Knowles; K Attkiss
Journal:  Ann Plast Surg       Date:  2000-10       Impact factor: 1.539

10.  Docetaxel extravasation into the normal breast during breast cancer treatment.

Authors:  Nagi S El Saghir; Zaher K Otrock
Journal:  Anticancer Drugs       Date:  2004-04       Impact factor: 2.248

View more
  2 in total

Review 1.  Taxanes: vesicants, irritants, or just irritating?

Authors:  Meagan S Barbee; Taofeek K Owonikoko; R Donald Harvey
Journal:  Ther Adv Med Oncol       Date:  2014-01       Impact factor: 8.168

2.  Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report.

Authors:  Pei-Hung Chang; Mei-Ti Wang; Yi-Hua Chen; Yu-Ying Chen; Cheng-Hsu Wang
Journal:  Oncol Lett       Date:  2014-02-27       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.